Login to Your Account

$98M for Phase III Allergy Vaccines Studies

Circassia Lands 3rd Largest Biotech Funding in Europe

By Nuala Moran

Wednesday, April 20, 2011
LONDON – Circassia Ltd. claimed the third largest funding round by a European biotech in the past 15 years, raising £60 million (US$98 million) in a fourth round. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription